BRIEF-Gilead Provides Update on Phase 3 ASCENT-07 Study
Reuters
Nov 07
BRIEF-Gilead Provides Update on Phase 3 ASCENT-07 Study
Nov 7 (Reuters) - Gilead Sciences Inc GILD.O:
GILEAD PROVIDES UPDATE ON PHASE 3 ASCENT-07 STUDY
GILEAD: PHASE 3 ASCENT-07 STUDY DID NOT MEET PRIMARY ENDPOINT OF PROGRESSION-FREE SURVIVAL
GILEAD: SAFETY PROFILE WAS CONSISTENT WITH PRIOR TRODELVY BREAST CANCER STUDIES AND NO NEW SAFETY SIGNALS WERE IDENTIFIED IN THIS PATIENT POPULATION
Source text: ID:nBwbmJ22Za
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.